Rise in Avoidable Diabetes Hospital Visits Hits England

Share on FacebookTweet about this on TwitterShare on Google+Share on RedditShare on StumbleUponEmail this to someoneShare on TumblrDigg this

University of Leicester researchers lead study into rising hypoglycemia admissions in hospitals, finding a significant increase over a 10 year period.

Hospital admissions for a short-term and avoidable diabetes complications have risen by 39-percent over the past ten years, according to a new analysis.

Hospital Emergency Entrance - Diabetes Health


The average cost per admission for the condition in England has been estimated to cost just over £1,000.

Approximately 80,000 people were admitted to the hospital in England for hypoglycaemia — where the blood sugar of a person with diabetes drops to dangerously low levels — for a total of 101,475 episodes between 2005 and 2014. This is according to an NIHR-supported study carried out at the Leicester Diabetes Centre.

The number of admissions for the low blood sugar episodes, also known as hypos, increased from 7,868 in 2005 to 11,756 in 2010, a 49-percent jump, and then 10,977 in 2014, a 39-percent jump, in ten years.

It represents a 14-percent hike if the general increase in hospital visits is taken into account, according to the research published in The Lancet Diabetes & Endocrinology journal.

Hospital length of stay, mortality, and one-month readmissions decreased progressively and consistently during the study period.

Professor Kamlesh Khunti, Professor of Primary Care Diabetes & Vascular Medicine at the University of Leicester based at the Leicester Diabetes Centre, who guided the team, said: “Given the continuous rise of diabetes prevalence, ageing population, and costs associated with hypoglycaemia, individual and national initiatives should be implemented to reduce the burden of hospital admissions for hypos.”

Accounting for diabetes prevalence, there was a reduction of admission rates, but Professor Khunti said this was down to an increase in newly-diagnosed people with Type 2 diabetes who have a much lower risk of hypoglycaemia.

More than 70-percent of the visits involved people aged 60 years or older.

The study was supported by the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) East Midlands, which turns research into cost-saving and high-quality care through cutting-edge innovation and the NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit, which harnesses the power of experimental science to explore and develop ways to help prevent and treat chronic disease.

This News Story Continues Below

The research, in collaboration with University of Nottingham, involved collecting data from the Hospital Episode Statistics where hypoglycaemia had been listed as the primary reason of admission between January 1, 2005, and December 31, 2014.

Lead researcher Dr Francesco Zaccardi, a Clinical Research Fellow at the University of Leicester based at the Leicester Diabetes Centre, said: “Studies in the USA and Canada have reported increasing or stable rates of hospital admissions for hypoglycaemia.

“With this study we gathered information about long-term trends in hospital admission for hypoglycaemia and subsequent outcomes in England to help widen understanding for the global burden of hospitalisation for hypoglycaemia.”

The average cost per admission for the condition in England has been estimated to cost just over £1,000. It is thought the total cost of treating severe hypoglycaemic episodes every year in the UK costs the NHS around £13 million.

Most hypoglycaemic episodes are generally mild and can be self-treated by eating or drinking glucose tablets, sweets, sugary fizzy drinks or fruit juice. But if untreated hypoglycaemic can lead to coma, hospitalisation and death.

For more information about the study, read the following article from the Lancet: Trends in hospital admissions for hypoglycaemia in England: a retrospective, observational study

Source: University of Leicester
Journal: Lancet Diabetes and Endocrinology
Funder: National Institute for Health Research

Save

What do you think about this story?

Share your thoughts, or see what other readers had to say, in the comments section (just scroll below).

Comment on this Story